I'd say a combination of both as there was clearly a drop in short positions too. Hopefully we will see some more exposure overseas with the new clinical trials moving forward and an appreciation in SP, it may need some more positive clinical data confirmation for this to re-rate properly though. In the meantime the market will do what it always does and the opportunity to make money will be capitalized on, but the longer term view is looking promising...
IMUGENE CHART. TA only, page-27667
-
- There are more pages in this discussion • 5,631 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.002(3.77%) |
Mkt cap ! $373.3M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 5.0¢ | $669.7K | 13.07M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1074997 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 1209633 | 6 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |